These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23008823)

  • 1. [Supportive care during chemotherapy for lung cancer in daily practice].
    Müller V; Tamási L; Gálffy G; Losonczy G
    Magy Onkol; 2012 Sep; 56(3):159-65. PubMed ID: 23008823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complementary therapy in NSCLC. Supportive treatment in thoracic oncology. Management of chemotherapy induced anaemia and neutropenia, nausea and vomiting and bone metastases].
    Bréchot JM
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S100-16S104. PubMed ID: 17268345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer].
    Wataya H; Ichinose Y
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():194-6. PubMed ID: 16898001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outpatient chemotherapy for breast cancer patients].
    Tanei T; Masuda N; Ishitobi M; Todaka K; Tanaka T; Ueno H
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():535-41. PubMed ID: 17682207
    [No Abstract]   [Full Text] [Related]  

  • 5. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.
    Chang AY; DeVore R; Johnson D
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical trial Furlutal in the prevention of anorexia, weight loss and myelosuppression due to chemotherapy].
    Wang J; Zhang P; Wang H
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):283-5. PubMed ID: 7587896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of some functions of polymorphonuclear granulocytes in lung cancer patients during chemotherapy].
    Panek B; Chyczewska E; Ossolińska M; Naumnik W; Izycki-Herman T; Korniluk M
    Pneumonol Alergol Pol; 2005; 73(2):167-71. PubMed ID: 16756147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E; Kamei T; Kimura K; Mukai J; Nakamura Y; Kunishige E; Fukuta K; Tani K; Sone S; Ogura T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3719-23. PubMed ID: 2556971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Administration of oral etoposide for one year as adjuvant chemotherapy for non-small cell lung cancer-side effect].
    Uchida T; Nakakawaji K; Sakamoto J
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1967-70. PubMed ID: 8978805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of bronchus carcinoma].
    Joss R; Buser K; Cerny T; Brunner KW
    Schweiz Rundsch Med Prax; 1989 Feb; 78(7):159-62. PubMed ID: 2538908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management and types of side effects in chemotherapy for lung cancer].
    Yoshida K
    Nihon Rinsho; 2002 May; 60 Suppl 5():384-7. PubMed ID: 12101694
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer.
    Felip E; Rosell R; Maestre JA; Rodríguez-Paniagua JM; Morán T; Astudillo J; Alonso G; Borro JM; González-Larriba JL; Torres A; Camps C; Guijarro R; Isla D; Aguiló R; Alberola V; Padilla J; Sánchez-Palencia A; Sánchez JJ; Hermosilla E; Massuti B;
    J Clin Oncol; 2010 Jul; 28(19):3138-45. PubMed ID: 20516435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of chemotherapy-induced anemia in lung cancer patients].
    Gálffy G
    Magy Onkol; 2013 Mar; 57(1):39-49. PubMed ID: 23573521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current progress in chemotherapy for bronchial cancer].
    Sculier JP
    Rev Med Brux; 1995; 16(2):55-63. PubMed ID: 7784737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of adverse events of amrubicin hydrochloride for pretreated lung cancer patients].
    Takase M; Maruoka H; Maeda R; Shibata K
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1789-92. PubMed ID: 18030011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chemotherapy in the treatment of lung cancer.
    Pate RW
    Nurs Clin North Am; 1992 Sep; 27(3):653-63. PubMed ID: 1324481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy and radiation therapy in lung cancer.
    Sause WT
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):72-8. PubMed ID: 8052877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.